Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000475224 | SCV000561569 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000506745 | SCV000602157 | likely benign | not provided | 2020-03-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000580944 | SCV000686446 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000506745 | SCV001867684 | benign | not provided | 2015-08-14 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000580944 | SCV002534800 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-27 | criteria provided, single submitter | curation | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492068 | SCV004239998 | uncertain significance | Breast and/or ovarian cancer | 2023-06-12 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000475224 | SCV005898272 | benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2024-12-13 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |
Prevention |
RCV003960101 | SCV004773727 | likely benign | RAD51D-related disorder | 2019-04-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |